24 October, zeng Fanwei, Deputy Secretary of the Party Committee and General Manager of Wuhan Construction Engineering Group Co., Ltd., and his entourage national Pharmaceutical Engineering study exchange. Chen Jinhui, Party Secretary and Director of Sinopa Engineering, deputy General Manager Li Haicheng, li Jianghai, General Manager of Engineering Center, mei Yu, Deputy General Manager of Marketing Department, etc. Plus exchange activities.

Meeting, Zeng Fanwei systematically introduced wuhan Construction Engineering Group development history, core business. He said that Wuhan Construction in large-scale public construction, municipal infrastructure, real estate development and other fields have accumulated rich experience, with excellent engineering quality and project management capabilities, in the industry won a good reputation. I hope to take this exchange as an opportunity to deeply connect with Sinopharm Engineering in the construction of pharmaceutical factories and related supporting infrastructure projects, and with the help of Sinopharm Engineering's professional capabilities and industry resources in the field of pharmaceutical engineering, further expand business areas and promote enterprises to achieve high-quality diversification development.

Chen Jinhui extended a warm welcome to Zeng Fanwei and his entourage, and introduced in detail the development history, business layout and professional advantages of Sinoparma Engineering. He said that Wuhan Construction Engineering has a solid practical foundation and systematic management capabilities in construction management and project execution, and its experience has important reference significance for the Sinopard Project to promote the construction of related projects. It is expected that the two parties can carry out in-depth cooperation in the field of engineering construction, give full play to their respective advantages in professional technology and engineering management, realize resource sharing and complementary capabilities, and jointly create a new model for cross-industry cooperation.

This exchange activity has built an efficient cooperation and communication bridge for both parties, and is an important measure for both parties to actively seek breakthroughs in cooperation. In the future, the two sides will establish a normalized communication mechanism, focusing on exploring cooperation directions such as coordination of pharmaceutical plant construction standards, co-construction of supporting infrastructure in industrial parks, and mutual learning of project management experience, so as to promote the deep integration of construction technology and pharmaceutical engineering needs and inject new impetus into the high-quality development of the pharmaceutical industry.

(Headquarters Marketing Department contribution)